Jim Fitzgerald Joins Flexan as Chief Executive Officer
CHICAGO, Illinois (June 22, 2015) – Flexan Medical Holdings, LLC announced today the appointment of Jim Fitzgerald as Chief Executive Officer. Mr. Fitzgerald joins a veteran executive team that includes Bruce Cohen, the President of Flexan and Frank Sullivan, the President of FMI.
“We are thrilled to partner with Jim as he knows the silicone contract manufacturing niche, understands the private equity model, and has the leadership experience, which I have seen first-hand, to scale this business,” said Linden Operating Partner Ron Labrum. Mr. Fitzgerald and Mr. Labrum worked together over a period of ten years at Cardinal Health. Mr. Labrum serves as Chairman of Flexan Medical Holdings, LLC.
“The Flexan team built a strong business and Linden recognized its potential as a growth platform,“ noted Mr. Fitzgerald. “I look forward to working with the Board and senior team to maintain and enhance the Company’s exemplary commitment to its customers while executing on strategic and operational initiatives to drive growth,” noted Mr. Fitzgerald.
Mr. Fitzgerald started his career with Allegiance Healthcare and Cardinal Health where he served a combined sixteen years in sales and general management roles capping his tenure as Executive Vice President for the $5.9 Billion Midwest Region. From Cardinal, he joined Vesta, a sponsor-backed contract manufacturer, as Executive Vice President responsible for Sales, Marketing, and Business Development. Most recently, Mr. Fitzgerald served since 2012 as the Chief Operating Officer at Institute for Transfusion Medicine.
Mr. Fitzgerald holds a Bachelor of Business Administration from the University of Notre Dame and a Master of Business Administration from the Kellogg School of Management at Northwestern University.
About Flexan Medical Holdings, LLC
Founded in 1946, Flexan is a leading global manufacturer of high-precision elastomer parts that are critical components in a broad array of products and industry applications. Headquartered in Chicago, IL, Flexan has over 500 employees and three manufacturing facilities, and operates two distinct but complementary business units (FMI and Flexan). FMI delivers clean-room manufactured silicone rubber molded components for use in Class II disposable and Class III implantable medical devices. Flexan is a custom molder whose expertise in molding difficult geometries and bonding rubber to metal has earned the company the reputation as an innovative provider across numerous attractive healthcare and industrial markets. For more information, please visit www.flexan.com and www.fmimed.com.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare.